GW Pharma (GWPH) to be acquired by Jazz Pharmaceuticals (JAZZ) for about $7.2 billion

• GW Pharmaceuticals (NASDAQ:GWPH) (UK-based) was acquired by Ireland-based Jazz Pharmaceuticals (NASDAQ:JAZZ) for $7.6 billion. (Completed in May 2021)